{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:42:37Z","timestamp":1740109357214,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["917.113.349"],"award-info":[{"award-number":["917.113.349"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["219707","409865"],"award-info":[{"award-number":["219707","409865"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["410778"],"award-info":[{"award-number":["410778"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tonix Pharmaceuticals"},{"DOI":"10.13039\/100009997","name":"International Headache Society","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/100009997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s10194-019-1003-2","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T16:04:18Z","timestamp":1556899458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery \u2013 potential antimigraine efficacy"],"prefix":"10.1186","volume":"20","author":[{"given":"Alejandro","family":"Labastida-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elo\u00edsa","family":"Rubio-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian A.","family":"Haanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Dammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J. J. C.","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoon","family":"van den Bogaerdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander H. J.","family":"Danser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos M.","family":"Villal\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"issue":"9","key":"1003_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11886-014-0524-1","volume":"16","author":"S Sacco","year":"2014","unstructured":"Sacco S, Kurth T (2014) Migraine and the risk for stroke and cardiovascular disease. Curr Cardiol Rep 16(9):524. \n                    https:\/\/doi.org\/10.1007\/s11886-014-0524-1","journal-title":"Curr Cardiol Rep"},{"key":"1003_CR2","doi-asserted-by":"publisher","first-page":"i2610","DOI":"10.1136\/bmj.i2610","volume":"353","author":"T Kurth","year":"2016","unstructured":"Kurth T, Winter AC, Eliassen AH, Dushkes R, Mukamal KJ, Rimm EB et al (2016) Migraine and risk of cardiovascular disease in women: prospective cohort study. Bmj. 353:i2610. \n                    https:\/\/doi.org\/10.1136\/bmj.i2610","journal-title":"Bmj."},{"key":"1003_CR3","doi-asserted-by":"publisher","unstructured":"Levy D, Labastida-Ramirez A, MaassenVanDenBrink A (2018) Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia:0333102418771350. \n                    https:\/\/doi.org\/10.1177\/0333102418771350","DOI":"10.1177\/0333102418771350"},{"issue":"1","key":"1003_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10194-017-0811-5","volume":"18","author":"S Benemei","year":"2017","unstructured":"Benemei S, Cortese F, Labastida-Ramirez A, Marchese F, Pellesi L, Romoli M et al (2017) Triptans and CGRP blockade - impact on the cranial vasculature. J Headache Pain 18(1):103. \n                    https:\/\/doi.org\/10.1186\/s10194-017-0811-5","journal-title":"J Headache Pain"},{"issue":"1","key":"1003_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1056\/NEJMct0910887","volume":"363","author":"E Loder","year":"2010","unstructured":"Loder E (2010) Triptan therapy in migraine. N Engl J Med 363(1):63\u201370. \n                    https:\/\/doi.org\/10.1056\/NEJMct0910887","journal-title":"N Engl J Med"},{"key":"1003_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.01.005","volume":"186","author":"Elo\u00edsa Rubio-Beltr\u00e1n","year":"2018","unstructured":"Rubio-Beltran E, Labastida-Ramirez A, Villalon CM, MaassenVanDenBrink A (2018) Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy? Pharmacol Ther. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.005","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"1003_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/ern.11.193","volume":"12","author":"D de Souza Carvalho","year":"2012","unstructured":"de Souza Carvalho D, Barea LM, Kowacs PA, Fragoso YD (2012) Efficacy and tolerability of combined dipyrone, isometheptene and caffeine in the treatment of mild-to-moderate primary headache episodes. Expert Rev Neurother 12(2):159\u2013167. \n                    https:\/\/doi.org\/10.1586\/ern.11.193","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"1003_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1526-4610.2001.111006391.x","volume":"41","author":"FG Freitag","year":"2001","unstructured":"Freitag FG, Cady R, DiSerio F, Elkind A, Gallagher RM, Goldstein J et al (2001) Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache. 41(4):391\u2013398. \n                    https:\/\/doi.org\/10.1046\/j.1526-4610.2001.111006391.x","journal-title":"Headache."},{"issue":"2","key":"1003_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijgo.2006.06.018","volume":"95","author":"CR Campos","year":"2006","unstructured":"Campos CR, Yamamoto FI (2006) Intracerebral hemorrhage in postpartum cerebral angiopathy associated with the use of isometheptene. Int J Gynaecol Obstet 95(2):151\u2013152. \n                    https:\/\/doi.org\/10.1016\/j.ijgo.2006.06.018","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"1003_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jflm.2009.07.006","volume":"16","author":"JC Johnston","year":"2009","unstructured":"Johnston JC (2009) Life threatening intracerebral hemorrhage with isometheptene mucate, dichlorophenazine and acetaminophen combination therapy. J Forensic Legal Med 16(8):489\u2013491. \n                    https:\/\/doi.org\/10.1016\/j.jflm.2009.07.006","journal-title":"J Forensic Legal Med"},{"issue":"1","key":"1003_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1526-4610.1974.hed1401033.x","volume":"14","author":"RE Ryan","year":"1974","unstructured":"Ryan RE (1974) A study of midrin in the symptomatic relief of migraine headache. Headache. 14(1):33\u201342. \n                    https:\/\/doi.org\/10.1111\/j.1526-4610.1974.hed1401033.x","journal-title":"Headache."},{"key":"1003_CR12","doi-asserted-by":"publisher","unstructured":"Daugherty B, Gershell L, Lederman S (2015) (R)-isometheptene (IMH) binds to imidazoline-1 receptor and (S)-IMH increases blood pressure: potentially superior benefit to risk ratio for (R)-IMH as an analgesic for headache. Headache 55(53) Abstract PS20.172). \n                    https:\/\/doi.org\/10.1111\/head.12600","DOI":"10.1111\/head.12600"},{"issue":"12","key":"1003_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/cns.12192","volume":"19","author":"L Zhang","year":"2013","unstructured":"Zhang L, Zhao TY, Hou N, Teng Y, Cheng X, Wang B et al (2013) Generation and primary phenotypes of imidazoline receptor antisera-selected (IRAS) knockout mice. CNS Neurosci Ther 19(12):978\u2013981. \n                    https:\/\/doi.org\/10.1111\/cns.12192","journal-title":"CNS Neurosci Ther"},{"key":"1003_CR14","doi-asserted-by":"publisher","unstructured":"Perino S, Fried N, Oshinsky MI, Daugherty BL, Lederman S, Elliott M (2016) The (R) isomer of isometheptene decreases trigeminal sensitivity in a rat model of primary headache. Headache 56 Abstract PS62. \n                    https:\/\/doi.org\/10.1111\/head.12832","DOI":"10.1111\/head.12832"},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejphar.2017.07.020","volume":"812","author":"E Rubio-Beltran","year":"2017","unstructured":"Rubio-Beltran E, Labastida-Ramirez A, Hernandez-Abreu O, MaassenVanDenBrink A, Villalon CM (2017) Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats. Eur J Pharmacol 812:97\u2013103. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.020","journal-title":"Eur J Pharmacol"},{"key":"1003_CR16","unstructured":"Lederman S, Gershell LJ et al (2014) Isometheptene Isomer, United States Patent. \n                    https:\/\/patents.google.com\/patent\/US9403755B2\/en?q=R-isometheptene&oq=R-isometheptene\n                    \n                  ."},{"issue":"2","key":"1003_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/0333102414544977","volume":"35","author":"S Labruijere","year":"2015","unstructured":"Labruijere S, Chan KY, de Vries R, van den Bogaerdt AJ, Dirven CM, Danser AJ et al (2015) Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein. Cephalalgia. 35(2):182\u2013189. \n                    https:\/\/doi.org\/10.1177\/0333102414544977","journal-title":"Cephalalgia."},{"key":"1003_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0333102417739584","volume":"39","author":"A Labastida-Ramirez","year":"2019","unstructured":"Labastida-Ramirez A, Rubio-Beltran E, Villalon CM, MaassenVanDenBrink A (2019) Gender aspects of CGRP in migraine. Cephalalgia. 39:435\u2013444. \n                    https:\/\/doi.org\/10.1177\/0333102417739584","journal-title":"Cephalalgia."},{"issue":"2","key":"1003_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1526-4610.2006.00526.x","volume":"47","author":"S Gupta","year":"2007","unstructured":"Gupta S, Villalon CM, Mehrotra S, de Vries R, Garrelds IM, Saxena PR et al (2007) Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin. Headache. 47(2):225\u2013235. \n                    https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00526.x","journal-title":"Headache."},{"issue":"7","key":"1003_CR20","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160(7):1573\u20131576. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00873.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1003_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1046\/j.1468-2982.1997.1704525.x","volume":"17","author":"DJ Williamson","year":"1997","unstructured":"Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies. Cephalalgia. 17(4):525\u2013531. \n                    https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1704525.x","journal-title":"Cephalalgia."},{"issue":"1","key":"1003_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.CIR.98.1.25","volume":"98","author":"A MaassenVanDenBrink","year":"1998","unstructured":"MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR (1998) Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 98(1):25\u201330","journal-title":"Circulation."},{"issue":"2","key":"1003_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00210-002-0582-6","volume":"366","author":"C Giessler","year":"2002","unstructured":"Giessler C, Wangemann T, Silber RE, Dhein S, Brodde OE (2002) Noradrenaline-induced contraction of human saphenous vein and human internal mammary artery: involvement of different alpha-adrenoceptor subtypes. Naunyn Schmiedeberg's Arch Pharmacol 366(2):104\u2013109. \n                    https:\/\/doi.org\/10.1007\/s00210-002-0582-6","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"4","key":"1003_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00210-002-0582-6","volume":"5","author":"PR Urquilla","year":"1974","unstructured":"Urquilla PR, Marco EJ, Balfagon G, Lluch S (1974) Adrenergic mechanisms in cerebral blood vessels: effect of tyramine on the isolated middle cerebral artery of the goat. Stroke. 5(4):447\u2013452. \n                    https:\/\/doi.org\/10.1007\/s00210-002-0582-6","journal-title":"Stroke."},{"issue":"1","key":"1003_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s10194-017-0761-y","volume":"18","author":"A Labastida-Ramirez","year":"2017","unstructured":"Labastida-Ramirez A, Rubio-Beltran E, Hernandez-Abreu O, Daugherty BL, MaassenVanDenBrink A, Villalon CM (2017) Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats. J Headache Pain. 18(1):52. \n                    https:\/\/doi.org\/10.1186\/s10194-017-0761-y","journal-title":"J Headache Pain."},{"issue":"5","key":"1003_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/01.CIR.0000023896.70583.9F","volume":"106","author":"D Sun","year":"2002","unstructured":"Sun D, Huang A, Mital S, Kichuk MR, Marboe CC, Addonizio LJ et al (2002) Norepinephrine elicits \u03b2<sub>2<\/sub>\u2212receptor\u2013mediated dilation of isolated human coronary arterioles. Circulation. 106(5):550\u2013555","journal-title":"Circulation."},{"issue":"1","key":"1003_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/157016109787354150","volume":"7","author":"A Loesch","year":"2009","unstructured":"Loesch A, Dashwood MR (2009) On the sympathetic innervation of the human greater saphenous vein: relevance to clinical practice. Curr Vasc Pharmacol 7(1):58\u201367. \n                    https:\/\/doi.org\/10.2174\/157016109787354150","journal-title":"Curr Vasc Pharmacol"},{"issue":"26","key":"1003_CR28","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1016\/j.lfs.2003.10.033","volume":"74","author":"LF Valdivia","year":"2004","unstructured":"Valdivia LF, Centurion D, Perusquia M, Arulmani U, Saxena PR, Villalon CM (2004) Pharmacological analysis of the mechanisms involved in the tachycardic and vasopressor responses to the antimigraine agent, isometheptene, in pithed rats. Life Sci 74(26):3223\u20133234. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2003.10.033","journal-title":"Life Sci"},{"issue":"17","key":"1003_CR29","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1212\/WNL.0b013e3181f9626a","volume":"75","author":"MS Asghar","year":"2010","unstructured":"Asghar MS, Hansen AE, Kapijimpanga T, van der Geest RJ, van der Koning P, Larsson HB et al (2010) Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology. 75(17):1520\u20131526. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181f9626a","journal-title":"Neurology."},{"issue":"7","key":"1003_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/bjp.2008.334","volume":"155","author":"J Zeller","year":"2008","unstructured":"Zeller J, Poulsen KT, Sutton JE, Abdiche YN, Collier S, Chopra R et al (2008) CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. Br J Pharmacol 155(7):1093\u20131103. \n                    https:\/\/doi.org\/10.1038\/bjp.2008.334","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1003_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/bjp.2008.49","volume":"154","author":"CM Villalon","year":"2008","unstructured":"Villalon CM, Albarran-Juarez JA, Lozano-Cuenca J, Pertz HH, Gornemann T, Centurion D (2008) Pharmacological profile of the clonidine-induced inhibition of vasodepressor sensory outflow in pithed rats: correlation with alpha (2A\/2C)-adrenoceptors. Br J Pharmacol 154(1):51\u201359. \n                    https:\/\/doi.org\/10.1038\/bjp.2008.49","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1003_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0014-2999(01)01111-6","volume":"424","author":"S Akerman","year":"2001","unstructured":"Akerman S, Williamson DJ, Hill RG, Goadsby PJ (2001) The effect of adrenergic compounds on neurogenic dural vasodilatation. Eur J Pharmacol 424(1):53\u201358. \n                    https:\/\/doi.org\/10.1016\/S0014-2999(01)01111-6","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1003_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1526-4610.2010.01679.x","volume":"50","author":"DK Bhatt","year":"2010","unstructured":"Bhatt DK, Ploug KB, Ramachandran R, Olesen J, Gupta S (2010) Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the Dural artery. Headache 50(6):1017\u20131030. \n                    https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01679.x","journal-title":"Headache"},{"issue":"1","key":"1003_CR34","first-page":"403","volume":"290","author":"CA Fairbanks","year":"1999","unstructured":"Fairbanks CA, Wilcox GL (1999) Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther 290(1):403\u2013412","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-019-1003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-019-1003-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-019-1003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:07:08Z","timestamp":1588374428000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-019-1003-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1186\/s10194-019-1003-2","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"type":"print","value":"1129-2369"},{"type":"electronic","value":"1129-2377"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"9 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in human vessels were in accordance with the Medical Ethics Committee of the Erasmus Medical Centre. Animal Experimental protocols were approved by our institutional ethics committee (EMC permission protocol number 3393), in accordance with the European directive 2010\/63\/EU and the ARRIVE guidelines for reporting experiments in animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"47"}}